Search results
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 7 hours agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $550.00
ETF DAILY NEWS· 3 days agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective hoisted by equities researchers at Argus from $465.00 to $550.00 in a note issued to investors ...
Vertex (NASDAQ:VERX) Stock Price Up 2.1%
ETF DAILY NEWS· 4 days agoVertex, Inc. (NASDAQ:VERX – Get Free Report) shares rose 2.1% during trading on Friday . The company traded as high as $36.28 and last traded at $36.05. Approximately 197,675 ...
SageView Advisory Group LLC Boosts Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 2 days agoSageView Advisory Group LLC lifted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 176.4% in the 4th quarter, according to its most recent ...
Oracle Alpha Inc. Buys Shares of 870 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 5 days agoOracle Alpha Inc. bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the 4th quarter, Holdings Channel reports. The firm bought 870 ...
Oarsman Capital Inc. Has $2.26 Million Stock Position in Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 6 days agoOarsman Capital Inc. raised its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 13.2% in the fourth quarter, according to its most recent disclosure ...
StockNews.com Upgrades Vertex Pharmaceuticals (NASDAQ:VRTX) to “Strong-Buy”
ETF DAILY NEWS· 4 days agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors ...
Vanguard Group Inc. Buys 298,824 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 3 days agoVanguard Group Inc. grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.4% in the 4th quarter, according to its most recent filing with ...
Insider Sale: EVP and CMO Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance· 6 days agoOn June 12, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex...
Greenwood Capital Associates LLC Purchases 2,576 Shares of Vertex Pharmaceuticals Incorporated...
ETF DAILY NEWS· 3 days agoGreenwood Capital Associates LLC boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 11.3% in the fourth quarter, Holdings ...